17-32266296-A-C

Variant summary

Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2

The NM_138328.3(RHBDL3):ā€‹c.107A>Cā€‹(p.Glu36Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000625 in 1,454,846 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā˜…ā˜…).

Frequency

Genomes: š‘“ 0.00031 ( 0 hom., cov: 32)
Exomes š‘“: 0.000034 ( 0 hom. )

Consequence

RHBDL3
NM_138328.3 missense

Scores

2
2
15

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:2

Conservation

PhyloP100: 1.85
Variant links:
Genes affected
RHBDL3 (HGNC:16502): (rhomboid like 3) Predicted to enable serine-type endopeptidase activity. Predicted to be involved in proteolysis. Predicted to be integral component of membrane. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -8 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.013210207).
BS2
High AC in GnomAd4 at 47 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
RHBDL3NM_138328.3 linkuse as main transcriptc.107A>C p.Glu36Ala missense_variant 1/9 ENST00000269051.9 NP_612201.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
RHBDL3ENST00000269051.9 linkuse as main transcriptc.107A>C p.Glu36Ala missense_variant 1/91 NM_138328.3 ENSP00000269051 P1P58872-1
RHBDL3ENST00000431505.6 linkuse as main transcriptc.107A>C p.Glu36Ala missense_variant 1/81 ENSP00000394849
RHBDL3ENST00000538145.5 linkuse as main transcriptc.107A>C p.Glu36Ala missense_variant 1/81 ENSP00000442092 P58872-3
RHBDL3ENST00000578006.5 linkuse as main transcriptc.107A>C p.Glu36Ala missense_variant, NMD_transcript_variant 1/91 ENSP00000463941

Frequencies

GnomAD3 genomes
AF:
0.000303
AC:
46
AN:
151726
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00109
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000655
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000702
AC:
5
AN:
71260
Hom.:
0
AF XY:
0.0000488
AC XY:
2
AN XY:
40960
show subpopulations
Gnomad AFR exome
AF:
0.00348
Gnomad AMR exome
AF:
0.0000687
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.000483
GnomAD4 exome
AF:
0.0000338
AC:
44
AN:
1303012
Hom.:
0
Cov.:
25
AF XY:
0.0000280
AC XY:
18
AN XY:
642866
show subpopulations
Gnomad4 AFR exome
AF:
0.00134
Gnomad4 AMR exome
AF:
0.0000782
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000138
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00
Gnomad4 OTH exome
AF:
0.000111
GnomAD4 genome
AF:
0.000310
AC:
47
AN:
151834
Hom.:
0
Cov.:
32
AF XY:
0.000323
AC XY:
24
AN XY:
74226
show subpopulations
Gnomad4 AFR
AF:
0.00111
Gnomad4 AMR
AF:
0.0000654
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.000285
Hom.:
0
Bravo
AF:
0.000363
ExAC
AF:
0.0000448
AC:
1

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsOct 05, 2021The c.107A>C (p.E36A) alteration is located in exon 1 (coding exon 1) of the RHBDL3 gene. This alteration results from a A to C substitution at nucleotide position 107, causing the glutamic acid (E) at amino acid position 36 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
not provided Uncertain:1
Uncertain significance, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.16
BayesDel_addAF
Benign
-0.40
T
BayesDel_noAF
Benign
-0.36
CADD
Uncertain
24
DANN
Benign
0.96
DEOGEN2
Benign
0.017
T;T;.
Eigen
Benign
-0.37
Eigen_PC
Benign
-0.36
FATHMM_MKL
Benign
0.25
N
LIST_S2
Benign
0.60
T;T;T
M_CAP
Pathogenic
0.83
D
MetaRNN
Benign
0.013
T;T;T
MetaSVM
Benign
-0.86
T
MutationAssessor
Benign
1.4
.;L;L
MutationTaster
Benign
0.94
D;N
PrimateAI
Pathogenic
0.88
D
PROVEAN
Benign
-0.77
N;N;N
REVEL
Benign
0.082
Sift
Uncertain
0.029
D;T;T
Sift4G
Uncertain
0.028
D;T;T
Polyphen
0.65
.;P;.
Vest4
0.18, 0.17
MutPred
0.51
Loss of solvent accessibility (P = 0.0224);Loss of solvent accessibility (P = 0.0224);Loss of solvent accessibility (P = 0.0224);
MVP
0.85
MPC
0.62
ClinPred
0.035
T
GERP RS
2.5
Varity_R
0.14
gMVP
0.51

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs774735010; hg19: chr17-30593315; API